Clinical Trials Directory

Trials / Completed

CompletedNCT01089218

The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
241 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fever can develop after fiberoptic bronchoscopy (FB) in about 2.5 - 16 % of adult patients. We evaluated the impact of oral amoxicillin/clavulanate (AC) on incidence of postbronchoscopic fever and pneumonia.

Detailed description

For the population being undergone with bronchoscopy, the clinical signs and procedural measures for complication of bronchoscopy and cytokines will be checked.

Conditions

Interventions

TypeNameDescription
DRUGoral amoxicillin/clavulanate 1g (875/125mg)oral amoxicillin/clavulanate 1g (875/125mg) on the day of the procedure 30 minutes prior to the FB
DRUGcontrolno intervention with the same procedure of FB

Timeline

Start date
2008-04-01
Primary completion
2009-01-01
Completion
2010-02-01
First posted
2010-03-18
Last updated
2011-07-21

Source: ClinicalTrials.gov record NCT01089218. Inclusion in this directory is not an endorsement.

The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines (NCT01089218) · Clinical Trials Directory